Greenyn Biotechnology
TWD58.10
0
-TWD0.20-0.34% Friday 05:30
Statistics
Day High
58.4
Day Low
58.4
52W High
78.2
52W Low
56.5
Volume
1,020
Avg. Volume
-
Mkt Cap
1.57B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Apr 25
TWD3.60
Jun 24
TWD3.50
Apr 23
TWD3.90
Apr 22
TWD3.55
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
0.45%
1Y Growth
2.94%
Earnings
12NovExpected
Q4 2025
Q2 2026
Next
2.54
2.87
3.21
3.54
Expected EPS
N/A
Actual EPS
N/A
Financials
15.9%Profit Margin
Profitable915.32MRevenue
145.52MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Show more...
CEO
Pang Kuei Hsu
Employees
143
Country
Taiwan
ISIN
TW0006846009
Listings
0 Comments
Share your thoughts
FAQ
What is Greenyn Biotechnology stock price today?▼
The current price of 6846.TWO is TWD58.10 TWD — it has decreased by -0.34% in the past 24 hours. Watch Greenyn Biotechnology stock price performance more closely on the chart.
What is Greenyn Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Greenyn Biotechnology stocks are traded under the ticker 6846.TWO.
Is Greenyn Biotechnology stock price growing?▼
6846.TWO stock has risen by +0.87% compared to the previous week, the month change is a -4.75% fall, over the last year Greenyn Biotechnology has showed a -23.55% decrease.
What is Greenyn Biotechnology market cap?▼
Today Greenyn Biotechnology has the market capitalization of 1.57B
When is the next Greenyn Biotechnology earnings date?▼
Greenyn Biotechnology is going to release the next earnings report on November 12, 2026.
What is Greenyn Biotechnology revenue for the last year?▼
Greenyn Biotechnology revenue for the last year amounts to 915.32M TWD.
What is Greenyn Biotechnology net income for the last year?▼
6846.TWO net income for the last year is 145.52M TWD.
Does Greenyn Biotechnology pay dividends?▼
Yes, 6846.TWO dividends are paid annual. The last dividend per share was 3.6 TWD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Greenyn Biotechnology have?▼
As of September 05, 2026, the company has 143 employees.
In which sector is Greenyn Biotechnology located?▼
Greenyn Biotechnology operates in the Health & Wellness sector.
When did Greenyn Biotechnology complete a stock split?▼
Greenyn Biotechnology has not had any recent stock splits.
Where is Greenyn Biotechnology headquartered?▼
Greenyn Biotechnology is headquartered in Taichung, Taiwan.